Clark Capital Management Group, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Clark Capital Management Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $296,985 - $435,898	-25,211 Reduced 12.66%	173,858 $2.92 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $537,471 - $690,574	45,977 Added 30.03%	199,069 $2.33 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $122,394 - $192,425	10,643 Added 7.47%	153,092 $2.06 Million
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $2.04 Million - $3 Million	142,449 New	142,449 $2.36 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.